107-99-3

Basic information

• Product Name: 2-Chloroethyldimethylamine
• Synonyms: N-(2-Chloroethyl)dimethylamine;2-Chloroethyldimethylamine;Ethanamine, 2-chloro-N,N-dimethyl-;beta-(Dimethylamino)ethyl chloride;N,N-DIMETHYL-BETA-CHLOROETHYLAMINE;DIMETHYL2-CHLOROETHYLAMINE;N-(2-Chloroethyl)-N,N-dimethylamine;1-Chloro-2-(dimethylamino)ethane
• CAS NO: 107-99-3
• Molecular Formula: C₄H₁₀ClN
• Molecular Weight: 107.5819
• EINECS: 203-540-7
• Mol File: 107-99-3.mol

Chemical Properties

• Boiling Point: 160.72°C (rough estimate)
• Flash Point: -11.234 °C
• Appearance: /
• Density: 0.9903 (rough estimate)
• Vapor Pressure: 214mmHg at 25°C
• Refractive Index: 1.5320 (estimate)
• PKA: 8.40±0.28(Predicted)
• CAS DataBase Reference: 2-Chloroethyldimethylamine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Chloroethyldimethylamine(107-99-3)
• EPA Substance Registry System: 2-Chloroethyldimethylamine(107-99-3)

Safety Data

• Hazardous Substances Data: 107-99-3(Hazardous Substances Data)

Usage

Definition

ChEBI: A tertiary amino compound consisting of one 2-chloroethyl and two methyl groups covalently bound to a nitrogen atom.

Safety Profile

Poison by an unspecified route. A systemic irritant. Mutation data reported. When heated to decomposition it emits highly toxic fumes of Cland NOx.

Carcinogenicity

No studies by common exposure routes have been conducted. In addition, dimethyl(b-chloroethyl) amine (and its hydrochloride salt) has not been evaluated by the IARC for carcinogenic potential.

InChI:InChI=1/C4H10ClN/c1-6(2)4-3-5/h3-4H2,1-2H3

Upstream product

• 108-01-0 2-(N,N-dimethylamino)ethanol 
• 4584-46-7 (2-chloroethyl)dimethylamine hydrochloride 
• 23950-06-3 (-)-α-codeimethine 
• 1429034-73-0 2-hydroxy-N-((7-methoxy-2-oxo-2H-chromen-4-yl)methyl)-N,N-dimethylethanaminium 

Downstream Products

• 86178-63-4 maleic acid bis-(2-dimethylamino-ethyl ester) 
• 19249-04-8 bis-dimethylaminoethylsuccinate 
• 112357-06-9 N'-(5-bromo-[2]pyridyl)-N,N-dimethyl-ethylenediamine 
• 86-21-5 pheniramine 
• 116382-99-1 bis(2-dimethylaminoethyl)phthalate 
• 100970-51-2 dimethyl-(3-phenyl-3-thiazol-2-yl-propyl)-amine 
• 114492-73-8 dimethyl-[2-(5-phenyl-tetrazol-2-yl)-ethyl]-amine 
• 132-22-9 Chlorpheniramine 
• 86-22-6 brompheniramine 
• 101286-08-2 [3-(2-chloro-phenyl)-3-[2]pyridyl-propyl]-dimethyl-amine 
• 519-30-2 7-(2-dimethylamino-ethyl)-1,3-dimethyl-3,7-dihydro-purine-2,6-dione 
• 531-06-6 Methaferylene 
• 91-80-5 methapyrilene 
• 101117-32-2 N-benzyl-N',N'-dimethyl-N-thiazol-2-yl-ethylenediamine 

Relevant articles and documents

Direct subphthalocyanine conjugation to bombesin: Vs. indirect conjugation to its lipidic nanocarrier

Bombesin (BBN) was covalently bound to graftable subphthalocyanine (SubPc) or to a cholesterol derivative, a component of a liposome that encapsulates non-graftable SubPc. The latter bioconjugation approach was suitable to address the stability of SubPc and was achieved by copper-free click-chemistry on the outer-face of the liposome. Liposomes were purified (FPLC) and then analyzed in size (outer diameter about 60 nm measured by DLS). In vitro binding studies allowed to determine the IC50 13.9 nM for one component of the liposome, cholesterol, conjugated to BBN. Hence, azido- (or alkynyl-) liposomes give fluorophores with no reactive functional group available on their backbone a second chance to be (indirectly) bioconjugated (with bombesin).

Insights into the mechanism and catalysis of peptide thioester synthesis by alkylselenols provide a new tool for chemical protein synthesis

While thiol-based catalysts are widely employed for chemical protein synthesis relying on peptide thioester chemistry, this is less true for selenol-based catalysts whose development is in its infancy. In this study, we compared different selenols derived from the selenocysteamine scaffold for their capacity to promote thiol-thioester exchanges in water at mildly acidic pH and the production of peptide thioesters from bis(2-sulfanylethyl)amido (SEA) peptides. The usefulness of a selected selenol compound is illustrated by the total synthesis of a biologically active human chemotactic protein, which plays an important role in innate and adaptive immunity.

Preparation method of doxylamine succinate impurity C

The invention discloses a preparation method of a doxylamine succinate impurity C. The preparation method comprises steps as follows: alpha-phenyl-2-pyridinemethanol and an organic solvent are added to a reactor, stirred and dissolved, after air in the reactor is subjected to N2 replacement, alkali liquor is added, a 2-dimethylaminoethyl chloride solution is dropwise added during stirring, a mixed solution is heated to produce backflow and is cooled after the reaction, water is added to a reaction product, a mixture is layered and purified, and a target product is obtained. According to the preparation method, alpha-phenyl-2-pyridinemethanol is taken as a raw material and subjected to an elimination reaction with 2-dimethylaminoethyl chloride under the alkaline condition, and the target product is obtained; the method has the advantages of adopting mild reaction conditions and short synthesis route and being simple and convenient to operate and can be applied to qualitative and quantitative analysis of impurities in doxylamine succinate production, and therefore, quality standard of doxylamine succinate can be improved; the product is high in yield and purity.

Design, Synthesis, and Biological Evaluation of Scutellarein Derivatives Based on Scutellarin Metabolic Mechanism in Vivo

Three series of scutellarein derivatives have been designed and synthesized based on metabolic mechanism of scutellarin (1) in vivo. Their thrombin inhibition activities were tested through the analyzation of prothrombin time (PT), activated partial thromboplastin time (APTT), thrombin time (TT), and fibrinogen (FIB). The antioxidant activities of these target products were assessed by 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) assay and the ability to protect PC12 cells against H2O2-induced cytotoxicity, and their solubilities were evaluated by ultraviolet (UV) spectrophotometer. The results showed that the two isopropyl groups substituted derivative (18c) demonstrated stronger anticoagulant activity, better water solubility, and good antioxidant activity compared with scutellarein (2), which warrants further development of 18c as a promising agent for ischemic cerebrovascular disease treatment. Three series of scutellarein derivatives have been designed and synthesized based on metabolic mechanism of scutellarin (1) in vivo. The results of the biological evaluation showed that the two isopropyl groups substituted derivative (18c) demonstrated stronger anticoagulant activity, better water solubility, and good antioxidant activity compared with scutellarein (2), which warrants further development of 18c as a promising agent for ischemic cerebrovascular disease treatment.

Highly Water-Soluble Cyclopentadienyl and Indenyl Molybdenum(II) Complexes - Second Generation of Molybdenum-Based Cytotoxic Agents

A series of the cyclopentadienyl and indenyl molybdenum compounds bearing alkylammonium functions [(η5-Cp′)Mo(CO)2(N,NL)][BF4]2 were synthesized and characterized by analytical and spectroscopic methods. The structures of [{η5-C5H4CH2CH2NH(CH2)5}Mo(CO)2(4,7-Ph2-phen)][BF4]2 (4,7-Ph2-phen = 4,7-diphenyl-1,10-phenanthroline) and [(η5-C9H6CH2CH2NHMe2)Mo(CO)2(phen)][BF4]2 (phen = 1,10-phenanthroline) were determined by X-ray crystallography. All of the synthesized compounds exhibit high activity against the human leukemia cell lines MOLT-4 and HL-60. They are approximately one order of magnitude more active than cisplatin. This study has proven that the modification of the outer coordination sphere of molybdenum complexes has a strong impact on their activity and may be successfully used for the design of new highly cytotoxic active species. A series of highly cytotoxic molybdenum(II) complexes are synthesized, and their activity against MOLT-4 and HL-60 leukemia cells is established.

Isoflavone amide type derivative, preparation method and medical application thereof

The invention relates to the field of medicinal chemistry, and relates to an isoflavone amide type derivative, a preparation method and a medical application thereof, in particular to an isoflavone amide type derivative with the general formula (I), a preparation method thereof, medicine compositions including the isoflavone amide type derivative and a medical application thereof, especially an application of the isoflavone amide type derivative as a medicine for preventing or curing hyperlipemia, obesity or type II diabetes. The general formula (I) is shown in the description.

Synthesis of scutellarein derivatives to increase biological activity and water solubility

In order to improve the biological activity and water solubility of scutellarin (1), some derivatives of its main metabolite (scutellarein) were designed and synthesized. All the compounds were tested for their thrombin inhibition activity through the analyzation of thrombin time (TT), activated partial thromboplastin time (APTT), prothrombin time (PT) and fibrinogen (FIB). Their antioxidant activities were assessed by measuring their scavenging capacities toward 1,1-diphenyl-2-picrylhydrazyl radical (DPPH) and the ability to protect PC12 cells against H2O2-induced cytotoxicity, their water solubility were also assessed by ultraviolet (UV) spectrophotometer. The results showed that compound 8b demonstrated stronger anticoagulant and antioxidant activity, better water solubility compared with scutellarein (2), which warrants it as a promising agent for the treatment of ischemic cerebrovascular disease.

SELECTIVE ALLOSTERIC MODULATORS OF THE SEROTONIN TRANSPORTER

Compounds of formula (I) are provided wherein R1 represents H, CN and CF3; R2 represents 1-naphthyl, 3,5-dichlorophenyl, 4-(4-fluorophenylthio)phenyl or phenyl substituted with one or more substituent selected from halogen, methoxy, cyano, methyl and trifluorom ethyl; R3 and R4 independently represent H, C1-3-alkyl or R3 and R4 together with the carbon atom to which they are attached form a C4-6-cyclic alkyl; R5 and R6 independently represent H or C1-6-alkyl; n represents 1 or 2; and pharmaceutically acceptable acid addition salts thereof, provided that if n is 2 then R2 is not 1-naphthyl, which compounds are selective allosteric SERT ligands.

Photoinitiated release of an aziridinium ion precursor for the temporally controlled alkylation of nucleophiles

A photo-activatable aziridinium precursor has been developed to investigate the possibility of a photo-initiated traditional nucleophilic reaction. The photolysis of a quaternary amine yields a tertiary amine and has allowed us to temporally control aziridinium formation and subsequent alkylation of a colorimetric nucleophilic reporter molecule. We have also used this photo-initiated reaction to alkylate a sulfhydryl group. This new photo-initiated alkylation strategy is water-soluble and expands the toolkit of photo-activated crosslinkers for protein labeling research.

NOVEL PROCESS FOR SYNTHESIS OF ITOPRIDE AND ITS NOVEL INTERMEDIATE N-(4-HYDROXYBENZYL)- 3,4-DIMETHOXYBENZAMIDE

The present invention relates to a novel and improved process for the preparation of N-[4-[2-(dimethylamino)ethoxy]benzyl]-3,4-dimethoxybenzamide—known as Itopride, via a novel intermediate N-(4?hydroxybenzyl)-3,4-dimethoxybenzamide.